Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Elisa Arceci"'
Autor:
Nicholas J. Brady, Alyssa M. Bagadion, Richa Singh, Vincenza Conteduca, Lucie Van Emmenis, Elisa Arceci, Hubert Pakula, Ryan Carelli, Francesca Khani, Martin Bakht, Michael Sigouros, Rohan Bareja, Andrea Sboner, Olivier Elemento, Scott Tagawa, David M. Nanus, Massimo Loda, Himisha Beltran, Brian Robinson, David S. Rickman
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
The heterogeneity of tumor evolution from AR-positive, adenocarcinoma to AR-negative, neuroendocrine prostate cancer (NEPC) is not fully characterized. Here the authors generate a mouse model to show that Rb1 loss and MYCN overexpression accelerates
Externí odkaz:
https://doaj.org/article/02a3612e2f2a462990758033d59bb602
Autor:
Martin Bakht, Lucie Van Emmenis, Massimo Loda, Nicholas J. Brady, David M. Nanus, Hubert Pakula, Elisa Arceci, David S. Rickman, Brian D. Robinson, Vincenza Conteduca, Richa Singh, Olivier Elemento, Rohan Bareja, Michael Sigouros, Himisha Beltran, Scott T. Tagawa, Ryan Carelli, Francesca Khani, Alyssa M. Bagadion, Andrea Sboner
Publikováno v:
Nature Communications
Università degli studi di Foggia-IRIS
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
Università degli studi di Foggia-IRIS
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
Despite advances in the development of highly effective androgen receptor (AR)-directed therapies for the treatment of men with advanced prostate cancer, acquired resistance to such therapies frequently ensues. A significant subset of patients with r